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INTRODUCTION:  We  report  the ﬁrst  case  of  laparoscopic  sleeve  gastrectomy  with  loop  bipartition  (a
modiﬁed  form  of Santoro’s  operation)  in  the  treatment  of type  II diabetes  mellitus  associated  with  obesity.
PRESENTATION  OF  CASE:  A 46-year-old  gentleman  (baseline  BMI  32.9;  BW  98.5 kg) with  7-year  history
of  type  II diabetes  mellitus  (DM)  underwent  the  procedure  in  Hong  Kong.  The  control  of  DM  was  poor
even  with  intensive  medical  therapy  before  the  operation.  Standard  laparoscopic  sleeve  gastrectomy
(SG)  was  performed  and  a loop  gastroileostomy  was fashioned  at the  antrum  250  cm  from  the  ilececal
valve  without  division  of  the 1st  part of  duodenum  after  SG.  The  resultant  gastric  tube  has  two  outlets,
one  to the ﬁrst  part  of duodenum  and  the other to  the  ileum with  preferential  passage  of  food  through
the  gastroileostomy  as  shown  on subsequent  contrast  study.  The  patient’s  recovery  was  uneventful.  The
excess  BMI  loss  was 97%  with  complete  normalization  of  all metabolic  parameters  at 1-year  follow-up.
DISCUSSION: This  new  surgical  procedure  (sleeve  gastrectomy  with  loop  bipartition:  SG+LB)  was  evolved
and  derived  from  the combined  concepts  of sleeve  gastrectomy  with  transit  bipartition  (SG+TB),  single
anastomosis  duodenal-ileostomy  (SADI),  mini-gastric  bypass  (MGB)  and  duodenal-jejunal  bypass  (DJB)
with  less  nutritional  and  surgical  complications.
CONCLUSION: Sleeve  gastrectomy  with loop  bipartition  may  be a very  effective  and simple  operation
to  treat  uncontrolled  DM  associated  with  obesity  with  a  lot  of apparent  advantages  over most  current
metabolic  procedures  available  at the  moment.
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. Introduction
Type II diabetes mellitus associated with obesity is becoming a
orldwide epidemic and in most patients, the control of the dis-
ase is suboptimal even with maximum medical therapy currently
vailable. The evidence for surgical intervention of DM is emerging
nd the International Federation of Diabetes (IDF) has formally laid
own the recommendations recently. This has changed the whole
oncept and approach to this dreadful disease and opened the green
ight for the development of metabolic surgery.
The culprit of developing DM and obesity are associated with
he imbalance of foregut and hindgut alimentation (hyperal-
mentation of foregut and hypoalimentation of hindgut) due
Open access under CC BY-NC-No over ingestion of high-calorie, high-glycaemic index diet in
odern society.1 All current metabolic procedures such as gastric
ypass, duodenal switch (DS) and ileum interposition address
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and reverse this imbalance and their principles are based on the
foregut or hindgut theory or the combination of both. Santoro
et al. has recently reported his long-term data regarding sleeve
gastrectomy with transit bipartition (SG + TB), which is a similar
operation to DS but without complete exclusion of duodenum in
order to minimize nutritional complications.2 We  modiﬁed the
operation by performing a loop rather than Roux-en-Y bipartition
reconstruction in Santoro’s operation and we are reporting the
ﬁrst patient who underwent this operation, laparoscopic sleeve
gastrectomy with loop bipartition (SG + LB) in the treatment of
poorly controlled type II diabetes mellitus associated with obesity.
2. Case report
A  46-year-old gentleman with a 7-year history of type II dia-
betes mellitus underwent laparoscopic sleeve gastrectomy with
loop bipartition in a private hospital in November 2012 in Hong
Kong. He weighted 98.5 kg with BMI  32.9 kg/m2 before the oper-
ation. He also suffered from hypertension and hyperlipidaemia.
He required 50 units of Lantus® injection (insulin glargine, Sanoﬁ-
Aventis) daily and was on multiple medications to control his blood
se.pressure and lipid level. His glucose control was very poor even
with intensive medical therapy and behavioural modiﬁcations. His
baseline HbA1c was 10.1% and C-peptide was  1.8 nmol/L. In view of
his conditions, intestinal bypass in addition to sleeve gastrectomy
 Ltd. Open access under CC BY-NC-ND license.
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of SADI as popularized by Sanchez et al.3 In SG + LB, the limb lengthFig. 1. Sleeve gastrectomy with loop bipartition.
as offered to him. The patient was fully informed regarding the
odiﬁcation of this operation (sleeve gastrectomy with loop bipar-
ition) from the current metabolic procedures and formal consent
as obtained.
The  procedure was performed by minimally invasive approach
n French position with ﬁve ports (12 mm  at umbilicus,
 mm × 5 mm at right upper quadrant, 1 mm × 10 mm and 1 mm  ×
 mm at left upper quadrant and 1 mm × 5 mm ports at epigas-
rium for liver retraction) as in our standard laparoscopic sleeve
astrectomy. The greater curvature of stomach including the pos-
erior fundus was mobilized completely from pylorus to the angle
f His exposing the left crus of diaphragm. The greater curvature of
tomach was transected by a linear stapler (Echelon 60 Endopath
tapler and Cutter. 60 mm,  Ethicon, Cincinnati, OH) from antrum
6 cm from pylorus) to angle of His with 38 Fr. calibration tube and
he staple line was oversewn with suture. A loop gastroileostomy
50 cm from the ilececal valve was created at the dependent part of
he antrum with 2 layers of handsewn suture but without division
f the 1st part of duodenum. The resultant stomach tube has two
utlets, one to the ﬁrst part of duodenum through the pylorus and
ne to the terminal ileum through the gastroileostomy (Fig. 1). The
peration time was 189 min  with minimal blood loss. The staple
ine and anastomosis was tested with methylene blue test at the
nd of the procedure.
The  patient had an uneventful recovery. Oral contrast study was
erformed on Day 7, which revealed no leakage and preferential
assage of contrast through the gastroileostomy. The patient was
ept in the hospital for 10 days for diet education and blood glucose
onitoring. Upon discharge from the hospital, the patient did not
equire insulin injection and was put on oral hypoglycaemic agents
nd adjusted doses of anti-hypertensive medications.
The patient was monitored regularly in a standardized pathway
nd protocol after surgery. He was prescribed a high protein liq-
id diet for the ﬁrst two weeks and soft diet from week 3 to 4. A
egular diet was gradually introduced thereafter. He was put on
 proton pump inhibitor for one month and multivitamin supple-
ent. He was evaluated monthly at the outpatient clinic by his
ndocrinologist and our surgical team.
His metabolic parameters were completely normalized with
essation of all oral medications at 2-month. The patient reported
 change of bowel habit with increased frequency of passing
atus and bowel motion 2–3 times/day after the operation. Gas-
roscopy was performed at 6-month and it conﬁrmed patency at thePEN  ACCESS
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anastomosis. The patient had progressive weight loss throughout
the follow-up period with no major complaint except for occasional
mild itchiness of skin.
At  1-year follow-up, his BW and BMI  dropped from 98.5 to
69.8 kg and 32.9 to 23.3 kg/m2, respectively. The excess BMI  loss
was 97.0% with reference to ideal body weight at BMI  23 for an Asian
population. There was a signiﬁcant improvement of HBA1c level
from 10.1 at baseline to 4.8% at 1-year follow-up. The patient devel-
oped mild hypoalbuminaemia and anaemia with albumin level
decreased from 41 to 31 g/L and haemoglobin level from 13.8 to
11.5 g/dL after operation as compared to the baseline.
3.  Discussion
This new surgical procedure (sleeve gastrectomy with loop
bipartition; SG + LB) was  evolved and derived from the com-
bined concepts of sleeve gastrectomy with transit bipartition
(SG + TB),1,2 single anastomosis duodenal-ileostomy (SADI),3 mini-
gastric bypass (MGB)4–6 and duodenal–jejunal bypass (DJB)7–9 that
we have learnt from past years. We  believe the outcome of this
operation would be comparable to the above metabolic proce-
dures but with less nutritional issue and a much safer and easier
operation. Our ﬁrst patient had a remarkable early outcome with
complete resolution of DM and obesity at 1-year follow-up.
In  Hong Kong, the gold standard treatment of obesity and dia-
betes is sleeve gastrectomy (SG).10 We  are very satisﬁed with the
results of SG and the majority of our patients can achieve excellent
outcomes with the operation. Intestinal bypass added to SG, pri-
mary or staged, is only reserved and offered to those with extreme
obesity and poorly controlled DM.  Gastric bypass (both Roux-en-Y
and MGB) were not well received in Hong Kong for some rea-
sons, namely a relatively higher incidence of stomach cancer and
common bile duct stones in our locality.11 On the other hand, DS
is almost being abandoned in Asia due to the nutritional conse-
quences and complexity of surgery.12 As a result, DJB or SADI,
which is a complementary procedure to SG, is gaining popularity
in Asia countries recently.7–9 We  modiﬁed the Santoro’s operation
(SG + TB) by creating a loop bipartition at antrum instead and the
resultant reconstruction (SG + LB) in fact is a very similar operation
to the SADI and loop DJB but without division of the duodenum. As
shown by Santoro et al., the majority of nutrients and food still pref-
erentially pass through the gastroileostomy rather than through
the physiological sphincter, the pylorus and this observation obvi-
ate the necessity for complete exclusion of duodenum in SADI or
DJB.2
There are a lot of apparent advantages of this procedure over the
other current metabolic operations. First, SG + LB is very straight-
forward and simple to perform without the need for division of
duodenum. It is a single step complementary to SG and can be
accomplished easily by minimally invasive approach with a rela-
tively short operation time. It can be offered to patients as a primary
or staged operation for the treatment of obesity and DM.  In addi-
tion, from the experience of gastric cancer and ulcer surgery, we
anticipate that the gastroileostomy anastomosis fashioned at the
dependent part of the antrum in SG + LB rarely develops leakage
or serious morbidity. This anastomosis should be the most robust
and safest as compared to other procedures with minimal tension.
Moreover, without division of duodenum, it completely eliminates
the possibility of duodenal stump leakage, which can be trouble-
some in SADI, DJB or DS. The alimentary limb length we chose
(250 cm from ileal caecal valve) was derived from the experiencecan be adjusted and modiﬁed according to the patient’s BMI  and
DM status and the procedure can be reversed and converted to
other procedure if needed at ease. There are no foreign bodies, blind
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oops or excluded segments involved and the whole GI tract and
ile duct can be assessed by endoscopy if necessary after the opera-
ion. What is more important, the nutritional issue of this operation
hould be less prominent. One of the major problems of MGB  and
JB is that up to 5% of patients may  develop severe iron deﬁciency
naemia, which is related to the length of bilipancreatic limb being
ypassed.4–6 SG + LB preserves the foregut for iron absorption and
otentially diminish the severity and possibility of this complica-
ion. Last but not the least, there is a theoretical beneﬁt by adding
his step to SG to decrease the stomach tube pressure. This may
otentially minimize the staple line leakage rate in SG. It has been
hown that MGB  rarely develop staple line leakage at the angle of
is and this may  attribute to the omega loop created at the distal
nd of the stomach tube decreasing the tube pressure in MGB. At
he moment of time, we think LS + LB appears to be close to the ideal
etabolic surgery and exhibits a lot of advantages as compared to
ther procedures.
As  in MGB, we  foresee that there will still be controversial issues
nd potential criticisms for this operation namely bile reﬂux and
umping syndrome in non-diabetic patients. The debate is outside
he scope of this discussion. The bottom-line is that SG + LB can
e completely reversed for dumping or revised to Braun’s recon-
truction to eliminate bile reﬂux in case it happens in a minority of
atients undergoing this procedure.
. Conclusions
Sleeve gastrectomy with loop bipartition may  be proven to be a
ery effective, safe and simple operation with numerous theoret-
cal advantages over the current procedures for the treatment of
besity and diabetes. However, we need more experts to explore
nd investigate this operation before we can draw any solid con-
lusions.
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